Comparison of The Means of Argyrophilic Nucleolar Organizer Region (mAgNOR) Pre- and Post-Therapy in Nasopharyngeal Carcinoma Patients at Wahidin Sudirohusodo General Hospital Makassar

Freddy George Kuhuwael, Muhammad Fadjar Perkasa, Upik Anderiani Miskad, Abdul Qadar Punagi, Fatmawati Arsyad Said


BACKGROUND: Nasopharyngeal carcinoma (NPC) is malignant tumor growing in nasopharynx with a predilection in fossa Rossenmuller and nasopharyngeal roof. This research aimed to prove whether the means of argyrophilic nucleolar organizer region (mAgNOR) can predict the success of treatment in nasopharyngeal carcinoma patients.

METHODS: We used diagnostic test method with longitudinal design and purposive sampling technique. Endoscopic biopsy examination was performed on 15 nasopharyngeal carcinoma patients before and after therapy, 13 patients underwent chemotherapy and other two underwent chemoradiotherapy. Tumor tissues were stained and AgNOR was calculated.

RESULTS: Based on the tumor stage, sample characteristic showed 3 patients (20%) were in stage II, 3 patients (20%) in stage III, and 9 patients (60%) in stage IV, with pre- and post-therapy mAgNOR were 1.610±0.988 and 1.000±0.000, respectively in stage II, 1.100±0.092 and 1.000±0.000, respectively in stage III, 1.226±0.265 and 1.107±0.164, respectively in stage IV patients. Based on histopathology type, 4 patients (26.7%) had non keratinizing squamous cell carcinoma with pre- and post-therapy mAgNOR were 1.117±0.134 and 1.060±0.120, respectively, while 11 patients (73.3%) had undifferentiated squamous cell carcinoma with pre- and post-therapy mAgNOR were 1.335±0.528 and 1.065±0.146, respectively. Overall the pre-therapy were significantly higher than post-therapy mAgNOR. In subgroups there are significant differences in stage IV and type 3.

CONCLUSION: The values of AgNOR were decreased in all NPC stages and significantly decreased in undifferentiated squamous cell carcinoma. AgNOR can be used to predict the successfulness of therapy in NPC.

KEYWORDS: nasopharyngeal carcinoma, therapy, proliferation, mAgNOR

Full Text:



Tabuchi K, Nakayama M, Nishimura B, Hayashi K, Hara A. Early detection of nasopharyngeal carcinoma. Int J Otolaryngol. 2011; 2011: 1-6, CrossRef.

Sham JS, Wei WI, Zong YS, Choy D, Guo YQ, Luo Y, et al. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet. 1990; 335: 371-4, CrossRef.

Kuhuwael FG. Clinical aspects of nasopharyngeal carcinoma at Dadi Hospital and Wahidin Sudirohusodo Hospital in 1990-1999. Presented in: Scientific Meeting Periodic XV of Faculty of Medicine, Hasanuddin University. Makassar: Hasanuddin University; 2001.

Bastiana. Comparison of Head Neck Cancer Cases in Two Decades in Makassar [Thesis]. Makassar: Hasanuddin University; 2010.

Wei WI. Nasopharyngeal cancer. In: Bailey BJ, Johnson JT, editors. Head and Neck Surgery - Otolaryngology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p.1657-68, NLMID.

Yeh SA, Tang Y, Lui CC, Huang EY. Treatment outcomes of patient with AJCC stage IV C nasopharyngeal carcinoma: benefits of primary radiotherapy. Jpn J Clin Oncol. 2006; 36: 132-6, CrossRef.

Lica L, Rebecca F. Gale Encyclopedia of Medicine. 3rd ed; 2006 [Internet]. Radiation therapy [cited Jun 1, 2015]. Available from:

Pusztai L, Lewis CE, Yap E. Cell Proliferation in Cancer Regulatory Mechanism of Neoplastic Cell Growth. New York: Oxford University Press; 1996, NLMID.

Tubiana M, Deutrix J, Wambersie A. Introduction to Radiobiology. London: Taylor & Francis; 1990, NLMID.

Tjahjono. Analysis of proliferative activity of the cell cycle to determine the nature of the cancer prognosis. M Med Indones. 2002; 37: 1-7.

Trere D. AgNOR staining and quantification. Micron. 2000; 31: 127-31. CrossRef.

Heber E, Schwint AE, Sartor B, Nishihama S, Sánchez O, Brosto M, et al. AgNORs as an early marker of sensitivity to radiotherapy in gynecologic cancer. Acta Cytol. 2002; 46: 311-6, CrossRef.

Irawan. Relations AgNOR pre- and post-chemoradiation with radiation responses in patients with epidermoid carcinoma cervix uteri late stage [Thesis]. Semarang: Diponegoro University; 2008, article.

Crocker J, Nar P. Nucleolar organizer regions in lymphomas. J Pathol. 1987; 151: 111-8, CrossRef.

Taheri Z, Kadkhoda N. Carcinoma: Past, Present and Future Direction -- Deuture Direction [Thesis]. Sweden: Goteborg Univer University; 2007.

Punagi AQ, Savitri E. Nasopharyngeal Carcinoma Profile in the Teaching Hospital’s Medicaicine, Univerity of Hasanuddin Period January 2004 – June 2007. Makassar: Hasanuddin University; 2007.

Vilianty J, Kuhuwael FG. Relationship Analysis Diet and Environmental Risk Factors in Nasopharyngeal Carcinoma Patients at Dr. Wahidin Sudirohusodo Hospital Makassar [Thesis]. Makassar: Medical Faculty of Hasanuddin University; 2015.

Savitri E, Kuhuwael FG, Punagi AQ, Agus IG. HLA-α24 gen allele at peripheral blood samples and nasopharyngeal cytobrush in nasopharyngeal carcinoma patients in Makassar. Int J Bio Med Res. 2014; 5(3): 4350-4, article.

Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002; 12: 421-9, CrossRef.

Biswal BM, Othman NH. Correlation of nuclear morphometry and AgNORs score with radiation response in squamous cell cancers of the head and neck: a preeliminary study. Malays J Med Sci. 2010; 17: 19-26, PMID.

Kinoshita Y, Dohi M, Mizutani N, Ikeda A. Effects of preoperative radiation and chemotherapy on AgNOR counts in oral squamous cell carcinoma. J Oral Maxillofac Surg. 1996; 54: 304-7, CrossRef.

Manu SC, Rajaram BT, Rai R. Value of silver binding nucleolar organizer region (AgNOR) in squamous cell carcinomas of upper aero-digestive tract. Armed Forces Med J India. 2006; 62: 123-8, CrossRef.

Arora B, Jindal K, Kumar S, Rekhi B, Arora H, Arora DR. Quantitative evaluation of AgNORs in bone tumours. Pathology. 2003; 35: 106-8, CrossRef.

Ghazizadeh M, Sasaki Y, Araki T, Konishi H, Aihara K. Prognostic value of prolirative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses. Am J Clin Pathol. 1997; 107: 451-8, CrossRef.

Kentjono WA. Kemoterapi pada tumor ganas THT-kepala leher. In: Pendidikan Kedokteran Berkelanjutan III. Ilmu Penyakit Telinga Hidung Tenggorokan-Kepala Leher. Surabaya: Airlangga University; 2002. p.108-21.

Sukardja IDG. Clinical Oncology. Surabaya: Airlangga University Press; 2002.

Chen M, Lee JC, Lo S, Shen J. Argyrophilic nucleolar organizer region in oropharyngeal carcinoma and paraneoplastic ephitelia. Head Neck. 2003; 25: 395-9, CrossRef.


Indexed by:






The Prodia Education and Research Institute